VitroScan
PrivateLast Round
Health Holland
Grant
May 26, 2026
Total Funding Raised
$5.31M
Company Overview
VitroScan is a biotechnology company that provides a 3D micro-tumor testing platform designed to support precision treatment development for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VitroScan Comparables
Compare VitroScan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xsphera Biosciences | 89% | |
| Xilis | 87% | |
| Apricot Therapeutics AG | 86% |
VitroScan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Health Holland Grant | May 26, 2026 | ||||
| Grant | Apr 22, 2025 | ||||
| Grant | Dec 2, 2024 | ||||
| Grant | Sep 5, 2023 | ||||
| Grant | Aug 23, 2022 | ||||
Grant | Aug 15, 2019 |
VitroScan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KWF Dutch Cancer Society | Grant |
| EIT Health | Grant |
| Eurostars SME programme | Grant |
| Libertatis Ergo Holding | Seed |
| medical:forge Leipzig | Grant |
| Health~Holland | Health Holland Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2024
$2M grant round led by Biotech Booster
- Apr 11, 2019
$901K round with Libertatis Ergo Holding and Pieter Geelen.
VitroScan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VitroScan's valuation, stock price, and market status.
Is VitroScan a public or private company?
VitroScan is a private company.
What is the current stock price of VitroScan?
VitroScan is a private company, so its shares have no public market price. Caplight tracks VitroScan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VitroScan worth (valuation)?
Valuation information for VitroScan is not publicly available.
Can I buy VitroScan stock?
VitroScan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VitroScan's last funding round?
VitroScan's most recent funding round was Health Holland Grant on May 26, 2026.
Who are the main investors in VitroScan?
Key investors in VitroScan include KWF Dutch Cancer Society, EIT Health, Eurostars SME programme, Health~Holland.
Will VitroScan IPO soon?
No public IPO plans have been announced for VitroScan.
How can I track VitroScan secondary market activity?
Caplight tracks bids, offers, and trades in VitroScan's shares on secondary markets.